For research use only. Not for therapeutic Use.
Redaporfin is a photosensitizer used in photodynamic therapy (PDT) for cancer treatment. It is a porphyrin-based compound that, when activated by near-infrared light, produces reactive oxygen species (ROS), leading to the destruction of cancer cells through oxidative stress and apoptosis. Redaporfin has shown high selectivity for tumor tissue and limited damage to surrounding healthy tissue, making it a promising candidate for treating solid tumors. Its potent photodynamic activity and favorable pharmacokinetics make redaporfin a valuable tool in cancer research, offering a minimally invasive treatment option with precise tumor targeting.
| Catalog Number | I008347 |
| CAS Number | 1224104-08-8 |
| Synonyms | 2,4-difluoro-N-methyl-3-[10,15,20-tris[2,6-difluoro-3-(methylsulfamoyl)phenyl]-2,3,12,13,22,24-hexahydroporphyrin-5-yl]benzenesulfonamide |
| Molecular Formula | C48H38F8N8O8S4 |
| Purity | ≥95% |
| InChI | InChI=1S/C48H38F8N8O8S4/c1-57-73(65,66)33-17-5-21(49)37(45(33)53)41-25-9-11-27(61-25)42(38-22(50)6-18-34(46(38)54)74(67,68)58-2)29-13-15-31(63-29)44(40-24(52)8-20-36(48(40)56)76(71,72)60-4)32-16-14-30(64-32)43(28-12-10-26(41)62-28)39-23(51)7-19-35(47(39)55)75(69,70)59-3/h5-9,11,14,16-20,57-61,64H,10,12-13,15H2,1-4H3 |
| InChIKey | CKRVBMUJCFKRND-UHFFFAOYSA-N |
| SMILES | CNS(=O)(=O)C1=C(C(=C(C=C1)F)C2=C3CCC(=N3)C(=C4C=CC(=C(C5=NC(=C(C6=CC=C2N6)C7=C(C=CC(=C7F)S(=O)(=O)NC)F)CC5)C8=C(C=CC(=C8F)S(=O)(=O)NC)F)N4)C9=C(C=CC(=C9F)S(=O)(=O)NC)F)F |
